Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2016, Article ID 6843121, 6 pages
http://dx.doi.org/10.1155/2016/6843121
Case Report

Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal Ablation

1Department of Interventional Radiology, Tbilisi State Medical University, High Technology University Clinic, 0144 Tbilisi, Georgia
2Department of Immunology, Tbilisi State Medical University, 0177 Tbilisi, Georgia

Received 20 February 2016; Accepted 13 July 2016

Academic Editor: Melanie Deutsch

Copyright © 2016 Malkhaz Mizandari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Forner, J. M. Llovet, and J. Bruix, “Hepatocellular carcinoma,” The Lancet, vol. 379, no. 9822, pp. 1245–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Yang and L. R. Roberts, “Hepatocellular carcinoma: a global view,” Nature Reviews Gastroenterology & Hepatology, vol. 7, no. 8, pp. 448–458, 2010. View at Publisher · View at Google Scholar
  4. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Z.-H. Gao, D.-S. Bai, G.-Q. Jiang, and S.-J. Jin, “Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma,” World Journal of Hepatology, vol. 7, no. 1, pp. 40–43, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Y. Kim and J. W. Park, “Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future,” Liver Cancer, vol. 3, pp. 9–17, 2014. View at Google Scholar
  7. Y.-B. Zheng, Q.-W. Meng, W. Zhao et al., “Prognostic value of serum vascular endothelial growth factor receptor 2 response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization,” Medical Oncology, vol. 31, no. 3, article 843, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Quirk, Y. H. Kim, S. Saab, and E. W. Lee, “Management of hepatocellular carcinoma with portal vein thrombosis,” World Journal of Gastroenterology, vol. 21, no. 12, pp. 3462–3471, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Omata, L. A. Lesmana, R. Tateishi et al., “Asian Pacific Association for the study of the liver consensus recommendations on hepatocellular carcinoma,” Hepatology International, vol. 4, no. 2, pp. 439–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Forner, M. E. Reig, C. R. de Lope, and J. Bruix, “Current strategy for staging and treatment: the BCLC update and future prospects,” Seminars in Liver Disease, vol. 30, no. 1, pp. 61–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. W.-Y. Lau, B. Sangro, P.-J. Chen et al., “Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90,” Oncology, vol. 84, no. 5, pp. 311–318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Llovet, J. Bustamante, A. Castells et al., “Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials,” Hepatology, vol. 29, no. 1, pp. 62–67, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. R. T.-P. Poon, S. T. Fan, I. O.-L. Ng, and J. Wong, “Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification,” Annals of Surgery, vol. 237, no. 3, pp. 376–383, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Feng, M. Pai, M. Mizandari et al., “Towards the optimization of management of hepatocellular carcinoma,” Frontiers of Medicine in China, vol. 5, no. 3, pp. 271–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Mizandari, G. Ao, Y. Zhang et al., “Novel percutaneous radiofrequency ablation of portal vein tumor thrombus: safety and feasibility,” CardioVascular and Interventional Radiology, vol. 36, no. 1, pp. 245–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-H. Chen, W. Yang, K. Yan et al., “Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications,” World Journal of Gastroenterology, vol. 11, no. 40, pp. 6395–6401, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Toyoda, S. Kakizaki, K. Horiuchi et al., “Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome,” World Journal of Gastroenterology, vol. 12, no. 4, pp. 608–611, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. T. Wissniowski, J. Hünsler, D. Neureiter et al., “Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits,” Cancer Research, vol. 63, no. 19, pp. 6496–6500, 2003. View at Google Scholar · View at Scopus
  19. M. H. M. G. M. den Brok, R. P. M. Sutmuller, R. van der Voort et al., “In situ tumor ablation creates an antigen source for the generation of antitumor immunity,” Cancer Research, vol. 64, no. 11, pp. 4024–4029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Y. Ali, C. F. Grimm, M. Ritter et al., “Activation of dendritic cells by local ablation of hepatocellular carcinoma,” Journal of Hepatology, vol. 43, no. 5, pp. 817–822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. A. Dromi, M. P. Walsh, S. Herby et al., “Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity,” Radiology, vol. 251, no. 1, pp. 58–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Zerbini, M. Pilli, A. Penna et al., “Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses,” Cancer Research, vol. 66, no. 2, pp. 1139–1146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Kikodze, K. Mazmishvili, M. Iobadze et al., “Hepatocellular carcinoma: current and prospective immunotherapeutic strategies,” Georgian Medical News, no. 246, pp. 78–84, 2015. View at Google Scholar